425 related articles for article (PubMed ID: 37000654)
21. PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
van Beek L; McClay É; Patel S; Schimpl M; Spagnolo L; Maia de Oliveira T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066057
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites.
Altmeyer M; Messner S; Hassa PO; Fey M; Hottiger MO
Nucleic Acids Res; 2009 Jun; 37(11):3723-38. PubMed ID: 19372272
[TBL] [Abstract][Full Text] [Related]
23. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
[TBL] [Abstract][Full Text] [Related]
24. PARP2 Is the Predominant Poly(ADP-Ribose) Polymerase in Arabidopsis DNA Damage and Immune Responses.
Song J; Keppler BD; Wise RR; Bent AF
PLoS Genet; 2015 May; 11(5):e1005200. PubMed ID: 25950582
[TBL] [Abstract][Full Text] [Related]
25. [Influence of the Poly(ADP-Ribose) Polymerase 1 Level on the Status of Base Excision Repair in Human Cells].
Ilina ES; Kochetkova AS; Belousova EA; Kutuzov MM; Lavrik OI; Khodyreva SN
Mol Biol (Mosk); 2023; 57(2):285-298. PubMed ID: 37000656
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1.
Naumenko KN; Sukhanova MV; Hamon L; Kurgina TA; Alemasova EE; Kutuzov MM; Pastré D; Lavrik OI
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32947956
[TBL] [Abstract][Full Text] [Related]
27. Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways.
Ghosh R; Roy S; Kamyab J; Danzter F; Franco S
DNA Repair (Amst); 2016 Sep; 45():56-62. PubMed ID: 27373144
[TBL] [Abstract][Full Text] [Related]
28. The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers.
Kamaletdinova T; Fanaei-Kahrani Z; Wang ZQ
Cells; 2019 Dec; 8(12):. PubMed ID: 31842403
[TBL] [Abstract][Full Text] [Related]
29. Bridging of DNA breaks activates PARP2-HPF1 to modify chromatin.
Bilokapic S; Suskiewicz MJ; Ahel I; Halic M
Nature; 2020 Sep; 585(7826):609-613. PubMed ID: 32939087
[TBL] [Abstract][Full Text] [Related]
30. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
[TBL] [Abstract][Full Text] [Related]
31. Poly(ADP-ribose) polymerase-1 affects vasopressin-mediated AQP2 expression in collecting duct cells of the kidney.
Jang HJ; Park E; Jung HJ; Kwon TH
Am J Physiol Renal Physiol; 2024 Jan; 326(1):F69-F85. PubMed ID: 37855039
[TBL] [Abstract][Full Text] [Related]
32. Role of YB-1 in Regulation of Poly(ADP-Ribosylation) Catalyzed by Poly(ADP-Ribose) Polymerases.
Alemasova EE; Naumenko KN; Sukhanova MV; Lavrik OI
Biochemistry (Mosc); 2022 Jan; 87(Suppl 1):S32-S0. PubMed ID: 35501985
[TBL] [Abstract][Full Text] [Related]
33. Poly-ADP ribosylation in DNA damage response and cancer therapy.
Hou WH; Chen SH; Yu X
Mutat Res Rev Mutat Res; 2019; 780():82-91. PubMed ID: 31395352
[TBL] [Abstract][Full Text] [Related]
34. PARPs in genome stability and signal transduction: implications for cancer therapy.
Palazzo L; Ahel I
Biochem Soc Trans; 2018 Dec; 46(6):1681-1695. PubMed ID: 30420415
[TBL] [Abstract][Full Text] [Related]
35. Poly(ADP-ribosyl)ation of TIMELESS limits DNA replication stress and promotes stalled fork protection.
Rageul J; Lo N; Phi AL; Patel JA; Park JJ; Kim H
Cell Rep; 2024 Mar; 43(3):113845. PubMed ID: 38393943
[TBL] [Abstract][Full Text] [Related]
36. HTS discovery of PARP1-HPF1 complex inhibitors in cancer.
Kellett T; Noor R; Zhou Q; Esquer H; Sala R; Stojanovic P; Rudolph J; Luger K; LaBarbera DV
SLAS Discov; 2023 Dec; 28(8):394-401. PubMed ID: 37844763
[TBL] [Abstract][Full Text] [Related]
37. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
38. Slow Dissociation from the PARP1-HPF1 Complex Drives Inhibitor Potency.
Stojanovic P; Luger K; Rudolph J
Biochemistry; 2023 Aug; 62(16):2382-2390. PubMed ID: 37531469
[TBL] [Abstract][Full Text] [Related]
39. Poly(ADP-ribosyl)ation enhances nucleosome dynamics and organizes DNA damage repair components within biomolecular condensates.
Nosella ML; Kim TH; Huang SK; Harkness RW; Goncalves M; Pan A; Tereshchenko M; Vahidi S; Rubinstein JL; Lee HO; Forman-Kay JD; Kay LE
Mol Cell; 2024 Feb; 84(3):429-446.e17. PubMed ID: 38215753
[TBL] [Abstract][Full Text] [Related]
40. Single molecule detection of PARP1 and PARP2 interaction with DNA strand breaks and their poly(ADP-ribosyl)ation using high-resolution AFM imaging.
Sukhanova MV; Abrakhi S; Joshi V; Pastre D; Kutuzov MM; Anarbaev RO; Curmi PA; Hamon L; Lavrik OI
Nucleic Acids Res; 2016 Apr; 44(6):e60. PubMed ID: 26673720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
